KRYSKrystal Biotech, Inc.
$331.81+103% 1Y
$331.81
$161.1552 weeks$371.35
Is it growing?
Excellent
3 goodGrowing: revenue growing +23% year on year, earnings up +62% year on year, and operating margin widening (+6.1 points).
Revenue trend+23% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Earnings trend+62% in a year
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Margin direction+6.1 points operating
Trailing-twelve-month operating margin, 44.7% now against 38.6% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is KRYS growing?
- Years of annual history on file
- 10
Years of annual history on file · FY2016 to FY2025, as filed
Details›
- Revenue FY2021
- $0
- Revenue FY2022
- $0
- Revenue FY2023
- $51M
- Revenue FY2024
- $291M
- Revenue FY2025
- $389M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks